These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9310634)

  • 1. Early stopping of trials.
    Langer A
    Lancet; 1997 Sep; 350(9081):890-1. PubMed ID: 9310634
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Prospective reinfaction outcomes in the Thrombolytic Era Cardizem CD Trial (PROTECT).
    Goodman S; Langer A
    Can J Cardiol; 1997 Jul; 13(7):693, 696. PubMed ID: 9251584
    [No Abstract]   [Full Text] [Related]  

  • 3. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
    Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A
    Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A curious stopping rule from Hoechst Marion Roussel.
    Lancet; 1997 Jul; 350(9072):155. PubMed ID: 9250175
    [No Abstract]   [Full Text] [Related]  

  • 5. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators.
    Lamas GA; Pfeffer MA; Hamm P; Wertheimer J; Rouleau JL; Braunwald E
    N Engl J Med; 1992 Jul; 327(4):241-7. PubMed ID: 1535419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dilren efficacy in postmyocardial infarction patients].
    Bichan NA
    Klin Med (Mosk); 2001; 79(1):58-9. PubMed ID: 11234272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early closure of European Pimagedine trial. Steering Committee. Safety Committee.
    Viberti G; Slama G; Pozza G; Czyzyk A; Bilous RW; Gries A; Keen H; Fuller JH; Menzinger G
    Lancet; 1997 Jul; 350(9072):214-5. PubMed ID: 9250200
    [No Abstract]   [Full Text] [Related]  

  • 8. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.
    Gibson RS; Boden WE; Theroux P; Strauss HD; Pratt CM; Gheorghiade M; Capone RJ; Crawford MH; Schlant RC; Kleiger RE
    N Engl J Med; 1986 Aug; 315(7):423-9. PubMed ID: 3526151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of calcium antagonist trials in acute myocardial infarction.
    Roberts R
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III41-7. PubMed ID: 2691141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diltiazem and mortality and reinfarction after myocardial infarction.
    N Engl J Med; 1989 Jan; 320(2):123-4. PubMed ID: 2911287
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beneficial effects of diltiazem on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL; Yang YJ; You SJ; Jing ZC; Wu YJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):679-83. PubMed ID: 15932731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diltiazem comes in from the cold.
    Purcell H; Fox K
    Eur Heart J; 2001 Feb; 22(3):185-7. PubMed ID: 11161925
    [No Abstract]   [Full Text] [Related]  

  • 13. Charting the course of clinical research: from an inspired past to a promising future.
    Armstrong PW; Kaul P;
    Am Heart J; 2004 Aug; 148(2):190-2. PubMed ID: 15308986
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute myocardial infarction.
    Danchin N; De Benedetti E; Urban P
    Am Fam Physician; 2003 Aug; 68(3):519-21. PubMed ID: 12924835
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethics and industry-sponsored research.
    Kuebler C; Nimmo WS; von R; Gillings D; Morgan AT; Kendle C; Covington PS
    CMAJ; 2002 Mar; 166(5):579-80; author reply 582. PubMed ID: 11898930
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolysis and its sequelae. Calcium antagonists as potential adjunctive therapy.
    Roberts R
    Circulation; 1989 Dec; 80(6 Suppl):IV93-101. PubMed ID: 2513147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prevention of myocardial infarction: new horizons for pharmacotherapy. Introduction.
    Taylor SH
    Eur Heart J; 1996 Dec; 17 Suppl F():1-2. PubMed ID: 8960441
    [No Abstract]   [Full Text] [Related]  

  • 18. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of calcium channel blocking drugs after myocardial infarction.
    Moss AJ
    Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials: the pitfalls of interpretation.
    Lokhandwalla Y; Dalvi B
    Issues Med Ethics; 1998 Apr; 6(2):47-8. PubMed ID: 15011700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.